drugset / Trial / NCT07537413

Ceftriaxone Dosage for Non-Critical Community-Acquired Pneumonia

NCT07537413

Phase 4 Not yet recruiting 430 enrolled University of Maryland, Baltimore
RandomizedParallel-groupOpen-labelTreatment

Summary

Aim: Demonstrate the equivalent efficacy and superior safety of Ceftriaxone 1 gram daily compared with Ceftriaxone 2 grams daily among hospitalized patients with community-acquired pneumonia who are not admitted to the intensive care unit.\<p\> Hypothesis: Among hospitalized patients outside of the intensive care unit with community-acquired pneumonia who are prescribed Ceftriaxone, a dosage of 1 gram daily will be associated with an equivalent rate of clinical cure and fewer adverse events than a dosage of 2 grams daily.

Timeline

Start
2026-09-01
Primary completion
2027-08-31
Completion
2028-02-28

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ceftriaxone Other / unclassified 1 g Intravenous
Comparator Ceftriaxone Other / unclassified 2 g Intravenous

Indications